Publication date: September 2026 Source: Blood Immunology & Cellular Therapy, Volume 2, Issue 3 Author(s): Aimee M. Merino, Bartosz Grzywacz, Hayden Hamsher, Young Vue, Hazel Reilly, Benjamin Miller, Petra Krhovska, Colleen Forster, Zachary Davis, Laura Bendzick, Megan Weivoda, Neha Sharma, Anders Narum, Ryan Shanley, Martin Felices, Nicholas A. Zorko, Evren Alici, Jeffrey S. Miller
B7-H3 expression affects outcomes in myeloma and is targetable with an NK cell engager. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050597626000394?dgcid=rss_sd_all
B7-H3 expression affects outcomes in myeloma and is targetable with an NK cell engager. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S3050597626000394?dgcid=rss_sd_all
“B7-H3 expression affects outcomes in myeloma and is targetable with an NK cell engager.” Blood Immunology & Cellular Therapy.
@article{article38456,
title = {B7-H3 expression affects outcomes in myeloma and is targetable with an NK cell engager},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050597626000394?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez